Pharmaceutical giant under pressure: Eli Lilly loses ground on weak news
Pharmaceutical giant under pressure: Eli Lilly loses ground on weak news
Wall Street Closes Mixed as Nasdaq
The premium article will be available in
00:00:00The premium article will be available in00:00:00
Wall Street Closes Mixed as Nasdaq Hits New Record On Thursday, US stock markets ended the day with mixed results. The Dow Jones and S&P 500 slipped, while the Nasdaq reached an all-time closing high, overcoming a sharp drop in several major stocks. Eli Lilly Disappoints Investors Shares of Eli Lilly tumbled 14.1 percent after the company released data on its oral weight-loss drug, orforglipron. While the pharmaceutical giant raised its full-year earnings and revenue outlook, the trial results failed to meet market
Fresh articles are available only to premium users
Read analytics in early access, getting information first
Get
Download NOW!
No comments:
Post a Comment